首頁 > 市場調查報告書 > 醫療設備

生物材料

市場調查報告書

商品編碼

1741385

細胞外基質市場：按成分類型、按應用、按原料、按最終用戶、按產品類型、按技術、按治療領域、按功能、按生物材料類型、按最終用途行業、按地區

Extracellular Matrix Market, By Component Type, By Application, By Source, By End-User, By Product Type, By Technology, By Therapeutic Area, By Function, By Biomaterial Type, By End-Use Industry, By Geography

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

細胞外基質市場規模預計在 2025 年為 4,420 萬美元，預計到 2032 年將達到 7,480 萬美元，2025 年至 2032 年的年複合成長率為 7.8%。

分析範圍		分析詳細資訊
基準年	2024	市場規模（2025年）	4420萬美元
效能數據	2020-2024	預測期	2025-2032
預測期內的年複合成長率（2025-2032）	7.80%	預計金額（2032年）	7480萬美元

細胞外基材(ECM) 是由蛋白質和碳水化合物組成的複雜網路，為組織和器官內的細胞提供結構支撐。它在調節細胞行為（包括細胞黏附、遷移、增殖和分化）中起著關鍵作用。 ECM 也充當生長因子和細胞因子的儲存器，這些因子和細胞激素會影響各種細胞過程。

全球細胞外基質市場正經歷顯著成長，這得益於慢性病盛行率的上升、再生醫學需求的不斷成長以及組織工程技術的進步。人口老化加劇，導致心血管疾病、整形外科疾病、皮膚潰瘍等慢性疾病的發生，是推動市場成長的主要因素。此外，外科手術數量的增加以及對有效創傷治療解決方案的需求也推動了對細胞外基質產品的需求。

然而，市場面臨基於 ECM 的治療方法價格高昂、監管要求嚴格、報銷政策限制等挑戰。此外，醫療保健專業人員和患者對基於 ECM 的產品益處缺乏認知，阻礙了市場成長。

然而，市場提供了多種成長機會，例如開發基於 ECM 的創新產品、與學術和工業參與者的合作、擴大新興市場的產品系列等。此外，對個人化醫療的日益關注以及 ECM 技術與其他先進療法的整合為市場擴張提供了光明的前景。

總而言之，受慢性病發病率上升和再生藥物需求成長的推動，全球細胞外基質市場預計將在未來幾年大幅成長。然而，要充分發揮市場潛力，仍需應對高成本和認知度不足等挑戰。

市場動態：

全球細胞外基質市場受多種因素驅動，包括慢性病的流行、組織工程的進步以及再生醫學需求的不斷成長。日益成長的老齡化人口易患慢性病，這是市場成長的主要驅動力。此外，外科手術數量的增加以及對有效創傷治療解決方案的需求也推動了對細胞外基質產品的需求。

然而，市場面臨許多挑戰，例如基於ECM的療法高成本、監管要求嚴格以及報銷政策限制。基於ECM的療法成本高昂，限制了其覆蓋更廣泛的患者群體，成為市場成長的主要障礙。此外，ECM產品核准的嚴格監管要求以及部分地區有限的報銷政策也阻礙了市場擴張。

儘管面臨諸多挑戰，市場仍蘊含著許多成長機會。生物活性支架和組織工程構建體等創新細胞外基質 (ECM) 產品的開發，蘊含著巨大的市場拓展潛力。學術機構與產業參與者之間的合作可以進一步促進創新，加速先進細胞外基質 (ECM) 技術的發展。此外，隨著再生醫學需求的不斷成長，新興市場產品系列的拓展，也能為市場成長開闢新的途徑。

總而言之，全球細胞外基質市場受到慢性病的流行和再生藥物需求的不斷成長等因素的驅動。然而，高成本和監管要求等挑戰亟待解決，同時，技術創新和新興地區市場擴張等機會也亟待把握。

本報告的主要特點

本報告對全球細胞外基質市場進行了詳細分析，並以 2024 年為基準年，展示了預測期（2025-2032）的市場規模和年複合成長率。
它還強調了每個細分市場的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素和機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
透過本報告的見解，負責人和企業經營團隊可以就未來的產品發布、合作夥伴關係、市場擴張和行銷策略做出明智的決策。
「全球細胞外基質市場」報告涉及該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球細胞外基質市場的各種策略矩陣來更輕鬆地做出決策。

Thermo Fisher Scientific
DSM
Acelity（KCI Concepts）
Corning Incorporated
Baxter
FUJIFILM Holdings Corporation
Integra LifeSciences
CellSystems Biotechnologie Vertrieb GmbH
Biotime, Inc.
Trevigen, Inc.
Advanced BioMatrix
Collagen Matrix, Inc.
Merck KGaA
VWR International LLC
REPROCELL USA Inc.
BioLamina AB
Matricel GmbH
Tissue Regenix
Admedus
MIMETAS

第 17 章章節

分析方法
關於出版商

簡介目錄

Product Code: CMI6171

Extracellular Matrix Market is estimated to be valued at USD 44.2 Mn in 2025 and is expected to reach USD 74.8 Mn by 2032, growing at a compound annual growth rate (CAGR) of 7.8% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 44.2 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.80%	2032 Value Projection:	USD 74.8 Mn

Extracellular matrix (ECM) refers to the complex network of proteins and carbohydrates that provide structural support to cells within tissues and organs. It plays a crucial role in regulating cell behavior, including cell adhesion, migration, proliferation, and differentiation. The ECM also acts as a reservoir for growth factors and cytokines, influencing various cellular processes.

The global extracellular matrix market is witnessing significant growth due to the increasing prevalence of chronic diseases, rising demand for regenerative medicine, and advancements in tissue engineering. The market is driven by the growing aging population, which is more susceptible to chronic conditions such as cardiovascular diseases, orthopedic disorders, and skin ulcers. Additionally, the rising number of surgical procedures and the need for effective wound healing solutions are fueling the demand for ECM products.

However, the market faces challenges such as the high cost of ECM-based therapies, stringent regulatory requirements, and limited reimbursement policies. Moreover, the lack of awareness among healthcare professionals and patients about the benefits of ECM-based products hinders market growth.

Nevertheless, the market presents several opportunities for growth, including the development of innovative ECM-based products, collaborations between academic institutions and industry players, and the expansion of product portfolios in emerging markets. Furthermore, the increasing focus on personalized medicine and the integration of ECM technologies with other advanced therapies offer promising prospects for market expansion.

In conclusion, the global extracellular matrix market is poised for significant growth in the coming years, driven by the increasing prevalence of chronic diseases and the growing demand for regenerative medicine. However, challenges such as high costs and limited awareness need to be addressed to fully realize the market's potential.

Market Dynamics:

The global extracellular matrix market is driven by several factors, including the increasing prevalence of chronic diseases, advancements in tissue engineering, and the rising demand for regenerative medicine. The growing aging population, which is more susceptible to chronic conditions, is a key driver for market growth. Additionally, the rising number of surgical procedures and the need for effective wound healing solutions are fueling the demand for extracellular matrix products.

However, the market faces challenges such as the high cost of ECM-based therapies, stringent regulatory requirements, and limited reimbursement policies. The high cost of ECM-based therapies poses a significant barrier to market growth, limiting their accessibility to a larger patient population. Moreover, the stringent regulatory requirements for the approval of ECM-based products and the limited reimbursement policies in some regions hinder market expansion.

Despite these challenges, the market presents several opportunities for growth. The development of innovative ECM-based products, such as bioactive scaffolds and tissue-engineered constructs, holds immense potential for market expansion. Collaborations between academic institutions and industry players can further drive innovation and accelerate the development of advanced ECM technologies. Additionally, the expansion of product portfolios in emerging markets, where the demand for regenerative medicine is growing, can open up new avenues for market growth.

In conclusion, the global extracellular matrix market is driven by factors such as the increasing prevalence of chronic diseases and the rising demand for regenerative medicine. However, challenges such as high costs and regulatory requirements need to be addressed, while opportunities such as innovation and market expansion in emerging regions should be capitalized upon.

Key features of the study:

This report provides in-depth analysis of the global extracellular matrix market, including market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), with 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
Key companies covered as a part of this study include Thermo Fisher Scientific, DSM, Acelity (KCI Concepts), Corning Incorporated, Baxter, FUJIFILM Holdings Corporation, Integra LifeSciences, CellSystems Biotechnologie Vertrieb GmbH, Biotime, Inc., Trevigen, Inc., Advanced BioMatrix, Collagen Matrix, Inc., Merck KGaA, VWR International LLC, REPROCELL USA Inc., BioLamina AB, Matricel GmbH, Tissue Regenix, Admedus, and MIMETAS.
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, type upgrades, market expansion, and marketing tactics.
The global extracellular matrix market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global extracellular matrix market.

Detailed Segmentation:

Global Extracellular Matrix Market, By Component Type:
- Proteins
- Glycoproteins
- Proteoglycans
- Other ECM molecules
Global Extracellular Matrix Market, By Application:
- Regenerative Medicine
- Tissue Engineering
- Wound Healing
- Drug Delivery
- Cancer Research
- Others
Global Extracellular Matrix Market, By Source:
- Animal-Derived ECM
- Human-Derived ECM
- Synthetic ECM
Global Extracellular Matrix Market, By End-User:
- Research Institutes and Academic Centers
- Biotechnology and Pharmaceutical Companies
- Hospitals and Clinics
Global Extracellular Matrix Market, By Product Type:
- Hydrogels
- Scaffolds
- Decellularized ECM
- ECM Analogs
- Others
Global Extracellular Matrix Market, By Technology:
- 3D Bioprinting
- Nanotechnology
- Cell Culture Techniques
- Genetic Engineering
- Others
Global Extracellular Matrix Market, By Therapeutic Area:
- Orthopedics
- Dermatology
- Cardiology
- Neurology
- Oncology
- Others
Global Extracellular Matrix Market, By Function:
- Structural Support
- Cellular Communication
- Cell Adhesion
- Signal Transduction
Global Extracellular Matrix Market, By Biomaterial Type:
- Natural ECM
- Synthetic ECM
Global Extracellular Matrix Market, By End-Use Industry:
- Healthcare
- Research and Development
- Cosmetics
- Pharmaceuticals
- Others
Global Extracellular Matrix Market, By By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profiles:
- Thermo Fisher Scientific
- DSM
- Acelity (KCI Concepts)
- Corning Incorporated
- Baxter
- FUJIFILM Holdings Corporation
- Integra LifeSciences
- CellSystems Biotechnologie Vertrieb GmbH
- Biotime, Inc.
- Trevigen, Inc.
- Advanced BioMatrix
- Collagen Matrix, Inc.
- Merck KGaA
- VWR International LLC
- REPROCELL USA Inc.
- BioLamina AB
- Matricel GmbH
- Tissue Regenix
- Admedus
- MIMETAS

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Global Extracellular Matrix, By Component Type
- Market Global Extracellular Matrix, By Application
- Market Global Extracellular Matrix, By Source
- Market Global Extracellular Matrix, By End-User
- Market Global Extracellular Matrix, By Product Type
- Market Global Extracellular Matrix, By Technology
- Market Global Extracellular Matrix, By Therapeutic Area
- Market Global Extracellular Matrix, By Function
- Market Global Extracellular Matrix, By Biomaterial Type
- Market Global Extracellular Matrix, By End-Use Industry
- Market Global Extracellular Matrix, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
The increasing prevalence of chronic diseases
- Restraints
High cost of ECM-based therapies
- Opportunities
Development of innovative ECM-based products
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Extracellular Matrix Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Extracellular Matrix Market, By Component Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2020 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Glycoproteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Proteoglycans
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Other ECM molecules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Extracellular Matrix Market, By Application, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Regenerative Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Tissue Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Wound Healing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Drug Delivery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Cancer Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Extracellular Matrix Market, By Source, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Animal-Derived ECM
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Human-Derived ECM
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Synthetic ECM
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Extracellular Matrix Market, By End-User, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Research Institutes and Academic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Biotechnology and Pharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

9. Global Extracellular Matrix Market, By Product Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hydrogels
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Scaffolds
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Decellularized ECM
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
ECM Analogs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

10. Global Extracellular Matrix Market, By Technology, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
3D Bioprinting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Nanotechnology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Cell Culture Techniques
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Genetic Engineering
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

11. Global Extracellular Matrix Market, By Therapeutic Area, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Orthopedics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Dermatology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

12. Global Extracellular Matrix Market, By Function, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Structural Support
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Cellular Communication
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Cell Adhesion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Signal Transduction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

13. Global Extracellular Matrix Market, By Biomaterial Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Natural ECM
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Synthetic ECM
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

14. Global Extracellular Matrix Market, By End-Use Industry, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Healthcare
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Research and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Cosmetics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Pharmaceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

15. Global Extracellular Matrix Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021-2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End-User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Function, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Biomaterial Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use Industry, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End-User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Function, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Biomaterial Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use Industry, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End-User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Function, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Biomaterial Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use Industry, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End-User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Function, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Biomaterial Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use Industry, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End-User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Function, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Biomaterial Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use Industry, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End-User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Function, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Biomaterial Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End-Use Industry, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - North Africa
  - Central Africa
  - South Africa

16. Competitive Landscape

Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
DSM
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Acelity (KCI Concepts)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Corning Incorporated
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Baxter
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
FUJIFILM Holdings Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Integra LifeSciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
CellSystems Biotechnologie Vertrieb GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Biotime, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Trevigen, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Advanced BioMatrix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Collagen Matrix, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
VWR International LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
REPROCELL USA Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
BioLamina AB
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Matricel GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Tissue Regenix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Admedus
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
MIMETAS
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views